Special 4/2013

  • Genomic Therapies and Diagnostics

    In this issue:

    Genomic Therapies and Diagnostics

    Personalised Medicine and Companion Diagnostics are expected to drive growth in the pharmaceutical and diagnostics industries in the future.
    Biotech companies that have acquired expertise in biobanking, sequencing and -omics technologies, as well as in the development of biomarkers, will bene t from pharma’s hunger for personalised ’niche-busters’.

Volume 2016

Volume 2015

Volume 2014

Volume 2013

Volume 2012

© 2007-2016 BIOCOM


Current issue

All issues


All Events


Product of the week